Katherine Beebe

Chief Scientific Officer, Titan Pharmaceuticals.

Companies

Titan PharmaceuticalsBoard member Feb 11, 2021 to Oct 26, 2023¹
Titan PharmaceuticalsChief operating officer Feb 11, 2021 to Oct 26, 2023¹
Titan PharmaceuticalsPresident Feb 11, 2021 to Oct 26, 2023¹
Titan PharmaceuticalsChief Scientific Officer Feb 25, 2019 to Feb 25, 2019²

Holdings

Stock this person has reported owning, from the forms officers and directors file with the SEC. See the biggest insider stakes.

Shares held

Titan Pharmaceuticals TTNP66,250 shares³Oct 25, 2023

As of each latest filing. The line shows shares held over time.

Recent filings

Oct 25, 2023Granted 16,250 shares of Titan Pharmaceuticals³
Jul 26, 2023Granted 50,000 shares of Titan Pharmaceuticals⁴

Sources

The numbers on this page point here. Each one links to the record it came from.

1
SEC EDGARTitan Pharmaceuticals, Board member
2
SEC EDGARTitan Pharmaceuticals, Chief Scientific Officer
3
SEC EDGARTitan Pharmaceuticals shares after the filing of Oct 25, 2023
4
SEC EDGARForm 4 filed Jul 28, 2023